New On Robinhood

Annexon

$25.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.22 (-4.61%) Today
$0.00 (0.00%) As of 9:01 PM UTC after-hours

Why Robinhood?

You can buy or sell Annexon and other stocks, options, and ETFs commission-free!

About ANNX

Annexon, Inc. Common Stock, also called Annexon, is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in South San Francisco, CA. The listed name for ANNX is Annexon, Inc. Common Stock.

CEO
Douglas Love
Employees
24
Headquarters
South San Francisco, California
Founded
2011
Market Cap
947.53M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
142.16K
High Today
$26.70
Low Today
$24.86
Open Price
$26.50
Volume
53.37K
52 Week High
$31.94
52 Week Low
$15.33

Collections

ANNX Earnings

-$28.87
-$19.25
-$9.62
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 31, After Hours

You May Also Like

TA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure